Outpatient monitoring of anticoagulant therapy adherence via mobile application: an analysis of the required functions
https://doi.org/10.25881/18110193_2023_2_70
Abstract
Aim: study of patients with atrial fibrillation (AF) needs in terms of therapy monitoring using a mobile application (MА) and the development of the required functions of the MА.
Materials and methods: 96 patients, 18 years of age and older (mean age 57,3±11,9) with a diagnosis of AF receiving anticoagulant therapy were included. We developed a questionnaire to assess the needs of patients with AF in terms of the use of MA, which included questions regarding the readiness of patients to use the developed MA in everyday life, their expectations regarding its interface and functionality.
Results: To study the expectations, needs for certain functions, as well as fears when working with MA, 96 patients (100%) were surveyed. Based on the results of the survey, the main expectations from the developed product were identified as follows: communication with a doctor to control therapy — 96% of respondents (n = 92), improved adherence to therapy — 94% of respondents (n=90). The most common fear was an incomprehensible interface — 21% of respondents (n = 20). Mean age of patients «ready to use MA» was 54,2±12,2 vs. 60,3±10,3 in the group «not ready to use MA» (p = 0,01). Prompt communication with the doctor was considered as the most important function in MA (45 (47%)).
Conclusion: A study of the needs of patients with AF in terms of the developed MA showed that the most important parameters were the convenience and ease of use, and the most demanded function of the MA was the possibility of prompt communication with the doctor.
About the Authors
M. A. Dragunova
Cardiology Research Institute
Russian Federation
Russian Federation
DRAGUNOVA M.A., PhD
Tomsk
T. V. Moskovskikh
Cardiology Research Institute
Russian Federation
Russian Federation
MOSKOVSKIKH T.V.
Tomsk
V. A. Shamakov
National Research Tomsk State University
Russian Federation
Russian Federation
SHAMAKOV V.A.
Tomsk
D. M. Matsepuro
National Research Tomsk State University
Russian Federation
Russian Federation
MATSEPURO D.M., PhD
Tomsk
R. E. Batalov
Cardiology Research Institute
Russian Federation
Russian Federation
BATALOV R.E., DSc
Tomsk
References
1. Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int J Stroke. 2020; 1747493019897870. doi: 10.1177/1747493019897870.
2. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2020; ehaa612. doi: 10.1093/eurheartj/ehaa612.
3. Kirgizova MA, Batalov RE, Tatarsky BA, Popov SV. Atrial fibrillation and hypertension: current understanding of the pathogenesis, diagnosis, and treatment. The Siberian Journal of Clinical and Experimental Medicine. 2019; 34(3): 13-20 (In Russ.) doi: 10.29001/2073-8552-2019-34-3-13-20.
4. Varma N, Cygankiewicz I, Turakhia MP, et al. 2021 ISHNE/HRS/EHRA/APHRS Expert Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/ Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society. CircArrhythmElectrophysiol. 2021; 14(2): e009204. doi: 10.1161/CIRCEP.120.009204.
5. Decree of the Government of the Russian Federation of December 28, 2022 №2469. Official Internet portal of legal information(http://www.pravo.gov.ru) (In Russ.)
6. Mival O, Benyon D. User Experience (UX) design for medical personnel and patients. Requirements engineering for digital health. Springer, Cham, 2015: 117-131.
7. Archakov EA, Krivolapov SN, Usenkov SYu, Batalov RE, Popov SV, Khlynin MS. Мobile telemonitoring for early diagnosis of changes in patient conditions. The Siberian Journal of Clinical and Experimental Medicine. 2016; 31(2): 92-95. (In Russ.) doi: 10.29001/2073-8552-2016-31-2-92-95.
8. Healey JS, Martin JL, Duncan A, et al. Pacemaker-detected atrial fibrillation in patients with pacemakers: prevalence, predictors, and current use of oral anticoagulation. Can J Cardiol. 2013; 29(2): 224-8. doi: 10.1016/j.cjca.2012.08.019.
9. Varma N, Marrouche NF, Aguinaga L, et al. HRS/EHRA/APHRS/LAHRS/ACC/AHA Worldwide Practical Guidance for Telehealth and Arrhythmia Monitoring During and After a Pandemic. Journal of the American College of Cardiology. 2020; 76: 1363-74. doi: 10.1016/j.jacc.2020.06.019.
10. Gusev AV, Ivshin AA, Vladzymyrskyy AV. Healthcare in the smartphone: the situation in Russia. Russian Journal of Telemedicine and E-Health. 2021; 7(3): 21-3. (In Russ.) doi: 10.29188/2712-9217-2021-7-3-21-31.
11. Kapoor A, Andrade A, Hayes A, et al. Usability, Perceived Usefulness, and Shared Decision-Making Features of the AFib 2gether Mobile App: Protocol for a Single-Arm Intervention StudyJMIR Res Protoc. 2021; 10(2): e21986. doi: 10.2196/21986.
12. Biersteker TE, Schalij MJ, Treskes RW. Impact of Mobile Health Devices for the Detection of Atrial Fibrillation: Systematic Review. JMIR Mhealth Uhealth. 2021; 28; 9(4): e26161. doi: 10.2196/26161.
13. Weerahandi H, Ziaeian B, Fogerty RL, Jenq GY, Horwitz LI. Predictors for patients understanding reason for hospitalization. PLOS ONE. 2018; 13(4): e0196479. doi: 10.1371/journal.pone.0196479.
14. Eshmatov OR, Batalov RE, Archakov EA, et al. Efficacy and safety of anticoagulant therapy in patients with various forms of atrial fibrillation after interventional treatment. Results of a three-year follow-up. Kardiologiia. 2022; 62(8): 19-26. (In Russ.) doi: 10.18087/cardio.2022.8.n2046.
Review
For citations:
Dragunova M.A., Moskovskikh T.V., Shamakov V.A., Matsepuro D.M., Batalov R.E. Outpatient monitoring of anticoagulant therapy adherence via mobile application: an analysis of the required functions. Medical Doctor and Information Technologies. 2023;(2):70-79. (In Russ.) https://doi.org/10.25881/18110193_2023_2_70
Views:
16
Email this article 